Peer-reviewed veterinary case report
Myotonia with hyperadrenocorticism in 2 dogs treated with trilostane
By Nagata, Noriyuki & Yuki, Masashi·Published in The Canadian veterinary journal = La revue veterinaire canadienne·2015·Yuki Animal Hospital, Japan·View original on PubMed →
PetCaseFinder translated the abstract of this peer-reviewed paper into plain English so pet owners can read it. We do not publish original research — every detail traces back to the citation above. How we work →
Original publication title: Long-term outcome of myotonia associated with hyperadrenocorticism in 2 dogs.
- Species:
- dog
Plain-English summary
Two dogs were diagnosed with muscle stiffness (myotonia) linked to Cushing's disease (hyperadrenocorticism). They were treated with a medication called trilostane. One dog experienced some temporary improvement, while the other did not show any change. Despite the ongoing muscle stiffness, both dogs lived for several years after their diagnosis, indicating that while myotonia may not improve with treatment, it doesn't necessarily lead to a shorter life.
People also search for: dog muscle stiffness treatment · Cushing's disease in dogs · trilostane for dog myotonia
Abstract
Two dogs were diagnosed with myotonia associated with hyperadrenocorticism and treated with trilostane. One dog showed temporary improvement, but the other dog showed no improvement. The dogs survived 2383 and 1902 days, respectively. Findings suggest that myotonia persists despite treatment, but this condition is not associated with a poor prognosis for survival.
Find similar cases for your pet
PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.
Search related cases →Original publication on PubMed: https://pubmed.ncbi.nlm.nih.gov/26347041/